Building Bridges to Asian Healthcare Markets

India's pharmaceutical, life sciences and medical equipment markets are in the throes of rapid modernization. Drug discovery is underway among large Indian pharmaceutical firms; themselves ramping up research to levels formerly unseen. The pharmaceutical sector is now India's leading sector for direct foreign investment into the country having reached $340 million in 2004. Domestic investment in the sector exceeded $1 billion in 2005 with large portions of the investment being dedicated to company expansions. The biotechnology sector is now enjoying growth rates of 39 percent annually with industry valuations of nearly $710 million. Witin the healthcare industry, consolidations are occurring among drug companies, hospital groups, medical distributors and retail druggists and new service offerings are springing up such as contract research. Finally,India's adherence to new stricter intellectual property laws is changing generic drug manufacturing and sales. The 2005 India Medical Market Report provides an overview of this emerging healthcare market. The report includes salient narratives on top industry players, sector-specific and general economic statistics and important contact information to augment your firm's research. The 2005 India Medical Market Report is your firm's roadmap to one of Asia's key emerging markets and includes information on key therapeutic areas targeted by Indian drug companies as well as important joint venture information. The Report also includes information on new pharmaceutical and biotechnology polices and regulatory oversight and a look at the changing face of drug and medical equipment distribution.
For $1,995, you can order a copy of 2005 India Medical Market Report and begin your analysis of India's healthcare market. Order your copy today by downloading our PDF Report Order Form, completing the form and mailing it to us along with your payment. Please contact us directly if you wish to issue a purchase order.